Drugs Made In America Acquisition Corp.
(NASDAQ: DMAA)

Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.

10.345

+0.015 (+0.15%)
Range 10.330 - 10.345   (0.15%)
Open 10.330
Previous Close 10.330
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 3
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis